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VISITING IMMUNIZATION EXPERT INITIATIVE
• The Visiting Immunization Expert Initiative through the national
American Academy of Pediatrics provides support for immunization
experts to virtually visit organizations to address pediatric influenza and
Human Papillomavirus (HPV) in effort to help physicians and practice
staff make strong recommendations for HPV and pediatric influenza
vaccination.
• This presentation is supported by the Centers for Disease Control and
Prevention (CDC) of the U.S. Department of Health and Human Services
(HHS) through grant 5 NU38OT000282-03-00. The contents are those of
the author(s) and do not necessarily represent the official views of, nor
an endorsement, by CDC/HHS, or the U.S. Government.
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Dr. Humiston is a consultant to
•

Sanofi Pasteur, a vaccine manufacturer that does not make an HPV vaccine

•

Universities, including UCLA and University of Rochester

•

Not-for-profit organizations, including AAP and its chapters, Immunization Action
Coalition, and Immunize Kansas Coalition

BY THE END OF THE WEBINAR,

YOU SHOULD

BE ABLE TO DO THE FOLLOWING:

1. Explain why HPV vaccine is important enough to be
routinely recommended for young people
(i.e., HPV cancer prevention).
2. Give an HPV vaccination recommendation that is
effective and succinct using the same way, same day
approach to the introduction of HPV vaccine.
3. Answer the most frequently asked questions about HPV
vaccine accurately and succinctly.

1: Why HPV vaccine is
important enough to be routinely
recommended for young people

NEW HPV-ASSOCIATED CANCER CASES EACH YEAR
BASED ON DATA FROM 2012-2016

Cervix

Oropharynx

Source: https://www.cdc.gov/cancer/us cs/about/ data-briefs/ no10-hpv-ass oc-cancers-Unite dStates-2012-2016.htm

CANCERS CAUSED BY THE 9 VACCINE TYPES OF HPV
PER YEAR, U.S., 2012–2016
Cancer site

% caused by 9
vaccine HPV types

Cervix

# probably caused by 9 vaccine types-HPV
Female

Male

Both Sexes

81%

9,700

0

9,700

Vagina

73%

600

0

600

Vulva

63%

2,500

0

2,500

Penis

57%

0

700

700

Anus*

88%

4,100

1,900

6,000

Oropharynx

66%

2,100

10,500

12,600

19,000

13,100

32,100

TOTAL
*Includes anal and rectal squamous cell carcinomas
Source: https://www.cdc.gov/mmwr/volumes/68/wr/mm6833a3.htm

OUR UNDERSTANDING OF HPVASSOCIATED CANCERS IS EVOLVING
Prostate cancer -causal role for HPVs is highly likely.

Source: Lawson and Glenn
https://www.ncbi.nlm.nih.gov/pmc/a rticles/ PMC7359253/

• HPV-associated cancers were defined as cancers at specific anatomic sites with
specific cellular types in which HPV DNA frequently is found.
• All cancers were confirmed histologically.
• Rates are per 100,000 and age-adjusted to the 2000 U.S. Standard Population
Source: https://gis.cdc.gov/Cancer/USCS/DataViz. htm l
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CREATE IMMUNIZATION CHAMPIONS

Be sure everyone in the office understands the mission
•

Human stories usually
influence people more
than statistics

•

To understand the human
stories behind HPV, listen
to survivors
o Shot By Shot.org
o ACS HPV survivor stories

OROPHARYNGEAL CANCER SURVIVOR

American Cancer Society
HPV Survivor – Frank Summers
https://www.youtube.com/watch?v=D2Ki-gC7OhM

A VIRUS THAT CAUSES CANCER…
EFFECTIVE, SAFE, LONG-LASTING
VACCINE… SO EVERYONE’S KNOCKING
DOWN THE DOOR

TO GET THEIR CHILD PROTECTED,
RIGHT?

Source:
https://app.powerbigov.us/view?r=eyJrIjoiMDY2OWM2ZmEtYjE2Yy00MTM5LWI5ZGUtODU5MGE1NWMxM2M4IiwidCI6I
jljZTcwODY5LTYwZGItNDRmZC1hYmU4LWQyNzY3MDc3ZmM4ZiJ9&pageName=ReportSection561f78b2709c4087d370

2: Identify patients for whom
HPV vaccine is recommended

ROUTINE ON-TIME VACCINATION

• Ages 9 through 14
• 2 doses (unless immunocompromised relative to HPV)
• Separated by 6-12 months (minimum 5 months)

Source: https://www.cdc.gov/hpv/hcp/schedules-recomm endations.htm l

Source: A Safe Return to In-Person Schooling: An Urgent Call to Action for Health Plans to Close the Adolescent Vaccination Care Gap webinar
www.ncqa.org/videos/a-safe-return-to-in-pers on-s chooling-a n-urgent-ca ll-to-a ction-for-hea lth-plans-to-clos e-the-adoles cent-vaccina tioncare-gap/

Source: https://www.cdc.gov/hpv/hcp/schedules-recomm endations.htm l

HPV VACCINE RECOMMENDATIONS-ROUTINE
•

•

Routine On-time Vaccination
o Ages 9 through 14
o 2 doses (unless immunocompromised relative to HPV)
o Separated by 6-12 months (minimum 5 months)

Routine Delayed Vaccination

o Ages 15 through 26
o 3 doses
o Doses 1 & 2 separated by 1-2 months (min 4 wks)
Doses 1 & 3 separated by 6 months (min 5 mos)
Doses 2 & 3 separated by at least 12 weeks
o If started at age 26, complete series when 27

If the series is interrupted, it does not need to be restarted.

HPV VACCINE RECOMMENDATIONS-SCDM
• For adult ages 27-45 years ACIP has voted to recommend
“shared clinical decision making”

• 3 doses, same schedule as young adults
• Risks? Very low
• Benefit?

Source: https://www.cdc.gov/vaccines/acip/recs/grade/HPV-adults-etr.html

3: Explain why HPV vaccine is more
likely to protect women from
fertility issues than to cause them

HPV VACCINATION

ELIMINATES

HPV INFECTION

HPV vaccination

AND THE DOWNSTREAM CONSEQUENCES

Source: Schiffman M et al., 2013

Genital HPV infection
79 million

Cervical
Pre-cancer
330,000

Cervical Cancer
12,000

CERVICAL CANCER DURING
CHILD-BEARING YEARS

38% of cervical cancers occur in women between the
ages of 20 & 44 years.

Source: http://seer.cancer.gov/statfacts/html/cervix.html

WITHOUT VACCINATION, ANNUAL BURDEN OF
GENITAL HPV-ASSOCIATED DISEASE IN U.S. FEMALES
4,000 cervical cancer deaths
10,846 new cases of cervical cancer
330,000 new cases of HSIL: CIN2/3
(high grade cervical intraepithelial neoplasia)

350,000 new cases of genital warts
1.4 million new cases of LSIL: CIN1(low
grade cervical intraepithelial neoplasia)
Source: American Cancer Society. 2008; Schiffman, Mark, and Philip E. Castle.; Koshiol
Sex Transm Dis. 2004; Insinga, Ralph P., Erik J. Dasbach, and Elamin H. Elbasha,
2005
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EVEN PRE-CANCEROUS LESIONS HAVE
IMPLICATIONS FOR A WOMAN AND HER OFFSPRING
New cases of cervical dysplasia each year in the US:

– 1.4 million low grade
– 330,000 high grade

Source: https://www.cancer.gov/types/cervical/understanding-abnormal-hpv-and-pap-testresults#treatment-for-high-grade-cervical-cell-changesnbsp
https://www.cdc.gov/hpv/partners/establishing-partners/prioritization.html
Picture: https://medlineplus.gov/ency/presentations/100080_4.htm

LEEP AND CONE BIOPSY
 May be used to treat moderate to severe types of
abnormal cell changes (CIN II or CIN III) or even very early
stage cervical cancer
 Subsequent pregnancies are at risk of

o Perinatal mortality
o Preterm delivery
o Low birth weight

VACCINE TYPE-HPV INFECTIONS, US FEMALES
20
15
61% decline

71% decline

10

Pre-vaccine era
2003-2006
Early vaccine era
2007-2010

5
0

14-19

20-24

Study also found vaccine type-HPV decreased 89% for vaccinated girls and
34% for unvaccinated girls: herd immunity
Source: Oliver, et al. JID 2017
https://academic.oup.com/ jid/article/216/5/594/3892427

COCHRANE REVIEW: HPV VACCINE
EFFECTIVENESS AGAINST CERVICAL PRECANCER
• Among previously un-infected women # of women who developed cervical precancer
o Placebo: 164 per 10,000 women
o HPV vaccine: 2 per 10,000 women who got the vaccine

• Regardless of infection status at outset HPV vaccines reduced the risk of cervical precancer
o Associated with HPV16/18:from 341 to 157/10 K
o Any precancer lesions:
from 559 to 391/10 K
Source: https://www.cochrane.org/news/ doe s-hpv-vaccination-prevent-development-ce rvica l-ca nce r-a re-there-ha rms-ass ociate d-be ing

October 2020

“We found that the
risk of cervical
cancer among
participants who
had initiated
vaccination before
the age of 17 years
was 88% lower than
among those who
had never been
vaccinated.”

4: Recommend this vaccine the same
way you recommend other vaccines

HOW EFFECTIVELY ARE WE
COMMUNICATING?
Our recommendations
matter to parents!
MN Dept of Health’s
“Just another shot: Reframing the
HPV vaccine”
https://www.youtube.com/watch?v=
vFHjK5L0t-Y&feature=emb_title
Source: http://www.health.state.mn.us/ divs/idepc/ imm unize/hcp/adol/ hpvvide os.html

OPTIONAL VERSUS HIGH QUALITY
• Optional approach: “Have you thought about what
shots you’d like to get today?”

o Unintentionally implies shot is not important or few get it
o 20-30% vaccination rate in studies of child & teen vaccines

• High quality: “Today we have some shots for you.”

o Implies shot is important and most people get it
o 70-90% vaccination rate in studies of child & teen vaccines

Sources: Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements vs conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139(1):e20161764
Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 2016;34(9):1187-1192
Opel DJ, Heritage J, Taylor JA, et al. The architecture of provider-parent vaccine discussions at health supervision visits.
Pediatrics. 2013;132(6):1037-1046

MAKE AN EFFECTIVE RECOMMENDATION
• Same day: Group all the adolescent vaccines,

recommend HPV vaccination the same way you
recommend Tdap & meningococcal vaccines
• Same day: Recommend HPV vaccine today,
i.e., the same day you recommend Tdap &
meningococcal vaccines
• Put HPV in the middle between Tdap &
meningococcal vaccines

PUTTING HIGH QUALITY

RECOMMENDATIONS INTO PRACTICE:
SAME WAY, SAME DAY
“Your child needs 3 vaccines today- Tdap, HPV and
meningococcal”
If starting before age 11, you can say:
“Today, your child needs the HPV vaccine to protect him against
cancers and other diseases caused by HPV.”

EVERY PART OF YOUR PRACTICE
INFLUENCES PARENTS’ PERCEPTIONS

THE OPENER BY THE NURSE/MA
• Encourage convenient same-day vaccination

“Today, Pat should have 3 vaccines to protect
him from meningitis, HPV cancers, and
pertussis. Do you have any questions for
me?”

• If a parents hesitates, the MA/nurse should say

“I’m sure the doctor will want to talk with you
about your concerns.”

5: Answering parents’ questions

Source: https://www.cdc.gov/hpv/hcp/for-hcp-tipshee t-hpv.pdf

TIP #1: REFLECT, ASK PERMISSION
Reflect back what the parent said to be sure he/she
understands (empathy) and asks permission to share
their own perspective.

“You feel that she’s too young for the HPV
vaccine because HPV is transmitted by
sexual activity. I can see what you’re
saying. I’ve thought a lot about this.
Is it okay if I tell you how I’ve come to
think about this?”

TIP #2: PROVIDE INFO TO CHANGE
PARENT’S PERSPECTIVE
“I used to think of this vaccine as something to
prevent a sexually transmitted disease, but realized
it’s really about preventing cancer.”
“We recommend it at this age because younger kids
have a better immune response. That’s why they need
only 2 doses instead of 3.”
This avoids arguing. You haven’t contradicted the parent’s point.

TIP #3: AVOID COUNTERING EMOTION

WITH DATA

What NOT to say: “Well data shows that

many adolescents will be having sex by middle school,
and if you’re worried about her having sex, studies
have shown that it won’t increase the likelihood of her
having sex.”

Statistics do not work in an
emotional argument.

TIP #4:

IF A PARENT DECLINES THE HPV VACCINE
• Declination is not final

•
•
•
•

o Many parents who decline, will vaccinate later
o The conversation should be revisited

Offer reading material
Don’t over-remember this
Relax. You’ve done your best for this child.
Waiting to vaccinate is the risky choice, so some
pediatricians ask parent to sign a Declination Form

HOW DO YOU HANDLE

OBJECTIONS BASED ON RELIGION?

EXAMPLE OF EFFECTIVE
PROVIDER COMMUNICATION
Minnesota Department of Health’s
“HPV vaccine: It’s effective”
https://www.youtube.com/watch?time_continue
=2&v=huyn7M8VmqI&feature=emb_title

Source:
http://www.health.state.mn.us/ divs/idepc/imm unize/hcp/adol/ hpvvide os.html

GREAT JOB!
• He seized the moment
• He did not “profile”
• He bundled the recommendation
• He asked for mom’s question
• He answered mom’s question accurately and calmly
• When mom asked the 2nd question:
“some people…”, he stayed positive
• He cared (“I’d feel better”)

6: Bring adolescents back to
your office

#CALLYOURPEDIATRICIAN CAMPAIGN

Source: https://www.aap.org/en-us/about-the-aa p/aap-press-room/cam paigns/ call-y our-pe dia tricia n/Pages/default.aspx

WHEN YOU HAVE OFFICE SYSTEMS GOING
WELL, ADD REMINDERS OR RECALL MESSAGES
• Use reminder or recall messages to bring adolescents in for
well care or missed vaccines
• EHR and state Immunization Information Systems (IIS) can
support this
• Many media: phone calls, letters, postcards, e-mail, text
messages, or patient portals, automated calling services

DON’T MISS ANY OPPORTUNITIES
• Nurse or technician prompts
• EHR prompts

EHR prompts alone may not work.
Source: Szilagyi et al Academic Pediatrics 2013

ANOTHER PAPER PROMPT

PAPER REMINDER/HUDDLE TOOL
Reason for visit:
Acute: __________________________________
WCC

ADHD

Screening:
Labs:

Asthm a

Hearing
Hct

Other___________

Vision
Lead

Other__________

Vaccines due:
<10 years:

2m o

4m o

6m o

12m o

≥10 years:

Tdap

HPV

Menactra

15m o

4 yr.

Flu

Varicella

Other________
Flu

Other________

Can be filled out day prior to visit or same day
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IF YOU CAN’T GIVE IT,
SCHEDULE IT

Wrap up

INCIDENCE
Annual Incidence (per
100,000)

8
7
6
5
4
3
2
1
0

OF DISEASES PREVENTABLE BY

ADOLESCENT VACCINES,

5.6

0.12

US

4.8

0.04

Sources: Meningococcal Disease, CDC, 2016, https://www.cdc.gov/meningococca l/downloa ds/NCIRD-EMS-Report.pdf; Pertussis, CDC, 2016,
https://www.cdc.gov/pertuss is/downloa ds/pe rtuss-surv-report-2016.pdf; HPV, CDC, 2011-2015, https://www.cdc.gov/cancer/ hpv/pdf/USCS-Data BriefNo4-August2018-508.pdf; www.cdc.gov/mmwr/volumes/67/wr/m m6733a2. htm#T 1_down
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AAP’S EQIPP: IMMUNIZATIONS –
STRATEGIES FOR SUCCESS

HTTPS://SHOP.AAP.ORG /EQIPP-IMMUNIZATIONS-STRATEGIES-FOR -SUCCESS/

• Free to AAP members
• Identify immunization rates in your practice, uncover
barriers to immunization delivery systems, and
provide techniques to overcome those barriers
through clear aims that reflect expert principles and
proven quality improvement methods and tools
• Choice of tracks
– 19-23 months old
– adolescent

WRAP UP

Patients for whom HPV vaccination is
recommended
HPV vaccination supports healthy
pregnancy
The presumptive recommendation for
HPV vaccination works
Plan to bring adolescents to your office
for vaccination
Evaluate how results of HPV vaccination
QI projects
could be applied in your office

